60 Degrees Pharmaceuticals, Inc.
SXTP News Today: Stay Updated with the Latest 60 Degrees Pharmaceuticals, Inc. News in Real Time
Find SXTP news now at Meyka AI. Stay informed with the latest 60 Degrees Pharmaceuticals, Inc. stocks updates, including price news, market analysis, and expert insights.
Revive Therapeutics Surges 33% on Clinical Pipeline Momentum
RVV.CN stock jumps 33% as Revive Therapeutics advances rare disease and psychedelic drug candidates. Market cap reaches C$17.4M.
RCMH Stock Plunges 80% Over One Year as Mobile App Developer Struggles
RCMH stock down 80% annually. Reach Messaging Holdings faces severe losses and negative cash flow in mobile app sector.
Viyash Scientific Limited Surges 10% on Strong Earnings Momentum
VIYASH.NS stock jumps 10% post-earnings with 251.69 price. Healthcare pharma company shows growth momentum on NSE.
SXTP Downgraded to Neutral from Buy at H.C. Wainwright
H.C. Wainwright downgraded SXTP to Neutral from Buy on May 20, 2026, citing concerns about the biotech firm’s pipeline and cash position.
Cyxtera Technologies Stock Trades at $0.065 Amid Restructuring
CYXT stock trades at $0.065 with massive debt burden and negative earnings. Data center provider faces significant financial challenges.
NTT, Inc. (9432.T) Rises 0.77% as Telecom Giant Holds Steady in Pre-Market
NTT, Inc. (9432.T) climbs 0.77% to ¥156.5 in pre-market trading on JPX. Telecom stock shows resilience with neutral rating.
Veren Inc. (VRN.TO) Surges 3.9% on Strong Energy Sector Momentum
VRN.TO stock jumps 3.9% to C$9.14 as oil and gas producer gains amid sector strength. Meyka AI rates VRN.TO with B+ grade.
DRVN Earnings Beat: Strong Q2 2026 Results Exceed Expectations
DRVN reported Q2 2026 earnings on May 19, 2026, beating EPS estimates by 41.67% with $0.34 actual vs $0.24 expected. Revenue also topped forecasts.
THR Earnings Beat Revenue, Misses EPS on May 19, 2026
Thermon Group Holdings (THR) reported Q2 2026 earnings on May 19, 2026. Revenue beat at $148.33M (+7.6%), but EPS missed at $0.55 vs $0.56 estimate.